Rohto Pharmaceutical Co Ltd
TSE:4527

Watchlist Manager
Rohto Pharmaceutical Co Ltd Logo
Rohto Pharmaceutical Co Ltd
TSE:4527
Watchlist
Price: 2 866 JPY 2.93% Market Closed
Market Cap: 676.9B JPY
Have any thoughts about
Rohto Pharmaceutical Co Ltd?
Write Note

Gross Margin
Rohto Pharmaceutical Co Ltd

57.4%
Current
58%
Average
31.7%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
57.4%
=
Gross Profit
161.8B
/
Revenue
282.1B

Gross Margin Across Competitors

Country JP
Market Cap 653.8B JPY
Gross Margin
57%
Country FR
Market Cap 181.7B EUR
Gross Margin
74%
Country UK
Market Cap 114.1B GBP
Gross Margin
0%
Country IN
Market Cap 5.5T INR
Gross Margin
52%
Country UK
Market Cap 34.9B GBP
Gross Margin
62%
Country DE
Market Cap 27.8B EUR
Gross Margin
58%
Country US
Market Cap 27B USD
Gross Margin
72%
Country JP
Market Cap 3T JPY
Gross Margin
38%
Country IN
Market Cap 1.1T INR
Gross Margin
56%
Country IN
Market Cap 903.7B INR
Gross Margin
49%
Country US
Market Cap 9.9B USD
Gross Margin
35%
No Stocks Found

Rohto Pharmaceutical Co Ltd
Glance View

Market Cap
653.8B JPY
Industry
Consumer products

Rohto Pharmaceutical Co Ltd., a company deeply rooted in the legacy of Japanese innovation, traces its beginnings to the late 19th century. Initially specializing in over-the-counter (OTC) medicines, it has adeptly expanded its reach to include skincare and healthcare products. The company’s journey from its inception was marked by a relentless pursuit of addressing the evolving needs of its consumer base, leveraging its expertise in pharmaceuticals and chemistry to create products that cater to health and wellness. Rohto's commitment to research and development has enabled it to pioneer unique formulations, effectively blending traditional practices with modern scientific advances. This strategy has allowed Rohto to establish a strong foothold not only in Japan but also in international markets, appealing to a broad demographic. The core of Rohto's business lies in its ability to commercialize its innovative solutions across various channels. The company generates revenue primarily through the sale of its diversified product lines, which include eye drops, dermatological creams, and other personal care products. Rohto’s strategic acquisitions and partnerships have also played a critical role in its growth, enabling it to expand its market presence and adapt to global health trends. The ability to anticipate and respond to consumer needs allows Rohto to maintain a robust product pipeline, ensuring consistent sales performance. Through its global distribution networks and focused marketing efforts, Rohto capitalizes on its brand reputation for quality and reliability, ensuring a steady stream of profits.

Intrinsic Value
3 201.93 JPY
Undervaluation 10%
Intrinsic Value
Price

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
57.4%
=
Gross Profit
161.8B
/
Revenue
282.1B
What is the Gross Margin of Rohto Pharmaceutical Co Ltd?

Based on Rohto Pharmaceutical Co Ltd's most recent financial statements, the company has Gross Margin of 57.4%.